Tang Capital Management
Latest statistics and disclosures from Tang Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TARS, GLPG, AUPH, PTCT, MIRM, and represent 23.00% of Tang Capital Management's stock portfolio.
- Added to shares of these 10 stocks: CELC (+$57M), PGEN (+$41M), NKE (+$35M), VRTX (+$27M), IONS (+$26M), PTCT (+$25M), AUPH (+$14M), VKTX (+$13M), JANX (+$12M), CMPX (+$12M).
- Started 12 new stock positions in Vor Biopharma, Athira Pharma, PASG, IDYA, GHRS, CRSP, PGEN, PMVP, CELC, CGTX. PACB, GOSS.
- Reduced shares in these 10 stocks: Iteos Therapeutics (-$38M), BA (-$22M), MTD (-$22M), CRGX (-$13M), ELAN (-$11M), Hillevax (-$9.8M), EPIX (-$7.3M), THRD (-$5.0M), SNY, NVAX.
- Sold out of its positions in ALXO, ACTU, ALGS, APLT, ATHA, CRGX, ELAN, EPIX, GALT, Hillevax. Iteos Therapeutics, MTSR, NVAX, Passage Bio, MCRB, SWTX, TPST, THRD.
- Tang Capital Management was a net buyer of stock by $186M.
- Tang Capital Management has $2.6B in assets under management (AUM), dropping by 31.31%.
- Central Index Key (CIK): 0001232621
Tip: Access up to 7 years of quarterly data
Positions held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 194 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals (TARS) | 5.6 | $146M | 2.5M | 59.43 |
|
|
| Galapagos Nv Spon Adr (GLPG) | 5.5 | $144M | +4% | 4.2M | 34.64 |
|
| Aurinia Pharmaceuticals (AUPH) | 4.8 | $125M | +12% | 11M | 11.05 |
|
| Ptc Therapeutics I (PTCT) | 3.5 | $92M | +36% | 1.5M | 61.37 |
|
| Mirum Pharmaceuticals (MIRM) | 3.5 | $91M | 1.2M | 73.31 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 3.5 | $90M | 2.3M | 38.83 |
|
|
| Immunocore Hldgs Ads (IMCR) | 3.2 | $84M | +9% | 2.3M | 36.33 |
|
| Kalvista Pharmaceuticals (KALV) | 2.4 | $61M | +2% | 5.0M | 12.18 |
|
| Miragen Therapeutics (VRDN) | 2.4 | $61M | 2.8M | 21.58 |
|
|
| Compass Therapeutics (CMPX) | 2.3 | $59M | +24% | 17M | 3.50 |
|
| Celcuity (CELC) | 2.2 | $57M | NEW | 1.2M | 49.40 |
|
| Merus N V (MRUS) | 2.2 | $57M | 600k | 94.15 |
|
|
| Spyre Therapeutics Com New (SYRE) | 2.1 | $54M | 3.2M | 16.76 |
|
|
| Relay Therapeutics (RLAY) | 1.6 | $42M | 8.1M | 5.22 |
|
|
| Lenz Therapeutics (LENZ) | 1.6 | $42M | 898k | 46.58 |
|
|
| Anaptysbio Inc Common (ANAB) | 1.6 | $41M | 1.3M | 30.62 |
|
|
| Precigen (PGEN) | 1.6 | $41M | NEW | 12M | 3.29 |
|
| Vera Therapeutics Inc Cl A Cl A (VERA) | 1.5 | $39M | 1.4M | 29.06 |
|
|
| Nike CL B (NKE) | 1.4 | $36M | +2577% | 519k | 69.73 |
|
| Ionis Pharmaceuticals (IONS) | 1.4 | $36M | +266% | 550k | 65.42 |
|
| Cytomx Therapeutics (CTMX) | 1.4 | $35M | 11M | 3.19 |
|
|
| Evolus (EOLS) | 1.3 | $34M | +9% | 5.5M | 6.14 |
|
| Avadel Pharmaceuticals Com Shs (AVDL) | 1.2 | $32M | 2.1M | 15.27 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $32M | 1.5M | 21.34 |
|
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $31M | +700% | 80k | 391.64 |
|
| Biosante Pharmaceuticals (ANIP) | 1.1 | $29M | 318k | 91.60 |
|
|
| Insmed Com Par $.01 (INSM) | 1.1 | $29M | 200k | 144.01 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.0 | $27M | 830k | 32.61 |
|
|
| Biontech Se Sponsored Ads (BNTX) | 1.0 | $27M | 270k | 98.62 |
|
|
| Liquidia Corporation Com New (LQDA) | 1.0 | $26M | 1.1M | 22.74 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.0 | $25M | 190k | 131.80 |
|
|
| NVIDIA Corporation (NVDA) | 0.9 | $24M | 131k | 186.58 |
|
|
| Viking Therapeutics (VKTX) | 0.9 | $23M | +135% | 870k | 26.28 |
|
| Keros Therapeutics (KROS) | 0.9 | $22M | 1.4M | 15.82 |
|
|
| Neurocrine Biosciences (NBIX) | 0.8 | $21M | 150k | 140.38 |
|
|
| Urogen Pharma (URGN) | 0.8 | $20M | 1.0M | 19.95 |
|
|
| Dynavax Technologies Corp Com New (DVAX) | 0.7 | $19M | 1.9M | 9.93 |
|
|
| Meta Platforms Cl A (META) | 0.7 | $19M | 26k | 734.39 |
|
|
| Zymeworks Del (ZYME) | 0.7 | $19M | 1.1M | 17.08 |
|
|
| GSK Sponsored Adr (GSK) | 0.7 | $17M | 400k | 43.16 |
|
|
| Janux Therapeutics (JANX) | 0.7 | $17M | +250% | 700k | 24.44 |
|
| Travere Therapeutics (TVTX) | 0.6 | $17M | 700k | 23.90 |
|
|
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $16M | +7% | 4.2M | 3.70 |
|
| Adma Biologics (ADMA) | 0.6 | $15M | 1.1M | 14.66 |
|
|
| Nkarta (NKTX) | 0.6 | $15M | 7.1M | 2.07 |
|
|
| Replimune Group (REPL) | 0.5 | $14M | +6% | 3.4M | 4.19 |
|
| Atea Pharmaceuticals (AVIR) | 0.5 | $14M | 4.8M | 2.90 |
|
|
| Design Therapeutics (DSGN) | 0.5 | $13M | 1.8M | 7.53 |
|
|
| Journey Med Corp (DERM) | 0.5 | $13M | 1.9M | 7.12 |
|
|
| Abcellera Biologics (ABCL) | 0.5 | $13M | 2.6M | 5.03 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.5 | $13M | +69% | 2.2M | 5.73 |
|
| Alibaba Group Holding Sponsored Ads (BABA) | 0.5 | $13M | 70k | 178.73 |
|
|
| Arvinas Ord (ARVN) | 0.5 | $12M | 1.4M | 8.52 |
|
|
| Stoke Therapeutics (STOK) | 0.5 | $12M | 500k | 23.50 |
|
|
| Vanda Pharmaceuticals (VNDA) | 0.5 | $12M | 2.4M | 4.99 |
|
|
| Sarepta Therapeutics (SRPT) | 0.4 | $12M | +42% | 600k | 19.27 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.4 | $12M | 150k | 76.72 |
|
|
| Summit Therapeutics (SMMT) | 0.4 | $11M | +120% | 550k | 20.66 |
|
| Ideaya Biosciences (IDYA) | 0.4 | $11M | NEW | 400k | 27.21 |
|
| Teladoc (TDOC) | 0.4 | $11M | 1.4M | 7.73 |
|
|
| Vaxcyte (PCVX) | 0.4 | $11M | 300k | 36.02 |
|
|
| Cybin Com New (CYBN) | 0.4 | $11M | 1.8M | 5.89 |
|
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.4 | $11M | 100k | 107.74 |
|
|
| Dianthus Therapeutics (DNTH) | 0.4 | $10M | 265k | 39.35 |
|
|
| IDEXX Laboratories (IDXX) | 0.4 | $10M | 16k | 638.89 |
|
|
| Ventyx Biosciences (VTYX) | 0.4 | $9.6M | 3.1M | 3.11 |
|
|
| Bioage Labs (BIOA) | 0.4 | $9.4M | 1.6M | 5.88 |
|
|
| Pliant Therapeutics (PLRX) | 0.3 | $8.9M | 6.0M | 1.48 |
|
|
| Bausch Health Companies (BHC) | 0.3 | $8.4M | +76% | 1.3M | 6.45 |
|
| Coherus Biosciences (CHRS) | 0.3 | $8.4M | 5.1M | 1.64 |
|
|
| Crescent Biopharma (CBIO) | 0.3 | $8.1M | +1255% | 680k | 11.89 |
|
| Altimmune Com New (ALT) | 0.3 | $8.0M | -22% | 2.1M | 3.77 |
|
| Apogee Therapeutics (APGE) | 0.3 | $7.9M | 200k | 39.73 |
|
|
| Moderna (MRNA) | 0.3 | $7.9M | 305k | 25.83 |
|
|
| Black Diamond Therapeutics (BDTX) | 0.3 | $7.8M | 2.1M | 3.79 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 0.3 | $7.7M | 281k | 27.56 |
|
|
| Eli Lilly & Co. (LLY) | 0.3 | $7.6M | 10k | 763.00 |
|
|
| Mineralys Therapeutics (MLYS) | 0.3 | $7.6M | 200k | 37.92 |
|
|
| Mind Medicine Mindmed Com New (MNMD) | 0.3 | $7.1M | 600k | 11.79 |
|
|
| Edgewise Therapeutics (EWTX) | 0.3 | $7.0M | 431k | 16.22 |
|
|
| Verastem Com New (VSTM) | 0.3 | $7.0M | +192% | 790k | 8.83 |
|
| Pmv Pharmaceuticals (PMVP) | 0.3 | $6.7M | NEW | 4.8M | 1.40 |
|
| Bausch Plus Lomb Corp Common Shares (BLCO) | 0.3 | $6.7M | -19% | 445k | 15.07 |
|
| Adicet Bio (ACET) | 0.3 | $6.7M | 8.2M | 0.81 |
|
|
| Cullinan Oncology (CGEM) | 0.3 | $6.6M | 1.1M | 5.93 |
|
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.2 | $6.5M | NEW | 100k | 64.81 |
|
| Beam Therapeutics (BEAM) | 0.2 | $6.2M | +24% | 255k | 24.27 |
|
| Genmab A/s Sponsored Ads (GMAB) | 0.2 | $6.1M | 200k | 30.67 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $6.1M | 800k | 7.59 |
|
|
| Immunitybio (IBRX) | 0.2 | $5.7M | 2.3M | 2.46 |
|
|
| Regeneron Pharmaceuticals (REGN) | 0.2 | $5.6M | 10k | 562.27 |
|
|
| Pyxis Oncology Common Stock (PYXS) | 0.2 | $5.6M | 2.5M | 2.22 |
|
|
| Cytokinetics Com New (CYTK) | 0.2 | $5.5M | 100k | 54.96 |
|
|
| Biogen Idec (BIIB) | 0.2 | $4.9M | 35k | 140.08 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $4.9M | +300% | 200k | 24.25 |
|
| Sanofi Sponsored Adr (SNY) | 0.2 | $4.7M | -50% | 100k | 47.20 |
|
| Revolution Medicines (RVMD) | 0.2 | $4.7M | 100k | 46.70 |
|
|
| Alumis (ALMS) | 0.2 | $4.7M | -41% | 1.2M | 3.99 |
|
| Heron Therapeutics (HRTX) | 0.2 | $4.3M | +61% | 3.5M | 1.26 |
|
| Nuvalent Inc-a (NUVL) | 0.2 | $4.3M | 50k | 86.48 |
|
|
| Theravance Biopharma (TBPH) | 0.1 | $3.9M | 264k | 14.60 |
|
|
| Tg Therapeutics (TGTX) | 0.1 | $3.6M | 100k | 36.12 |
|
|
| Precision Biosciences Com New (DTIL) | 0.1 | $3.6M | 654k | 5.52 |
|
|
| Cg Oncology (CGON) | 0.1 | $3.5M | 88k | 40.28 |
|
|
| Soleno Therapeutics (SLNO) | 0.1 | $3.4M | 50k | 67.60 |
|
|
| Alexandria Real Estate Equities (ARE) | 0.1 | $3.3M | 40k | 83.34 |
|
|
| Erasca (ERAS) | 0.1 | $3.3M | 1.5M | 2.18 |
|
|
| Fennec Pharmaceuticals (FENC) | 0.1 | $3.1M | +1530% | 335k | 9.36 |
|
| Syndax Pharmaceuticals (SNDX) | 0.1 | $3.1M | 200k | 15.38 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $2.9M | 900k | 3.27 |
|
|
| Seer Com Cl A (SEER) | 0.1 | $2.9M | 1.3M | 2.17 |
|
|
| Tectonic Therapeutic (TECX) | 0.1 | $2.8M | 179k | 15.69 |
|
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $2.8M | 720k | 3.90 |
|
|
| Rocket Pharmaceuticals (RCKT) | 0.1 | $2.8M | 850k | 3.26 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.1 | $2.6M | 50k | 51.29 |
|
|
| Neumora Therapeutics (NMRA) | 0.1 | $2.5M | 1.4M | 1.82 |
|
|
| Sutro Biopharma (STRO) | 0.1 | $2.5M | +10% | 2.8M | 0.87 |
|
| Vor Biopharma Com New | 0.1 | $2.4M | NEW | 50k | 48.72 |
|
| Kalaris Therapeutics (KLRS) | 0.1 | $2.4M | +15% | 418k | 5.78 |
|
| Mettler-Toledo International (MTD) | 0.1 | $2.4M | -89% | 2.0k | 1227.61 |
|
| Fate Therapeutics (FATE) | 0.1 | $2.4M | 1.9M | 1.26 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $2.3M | 1.6M | 1.51 |
|
|
| Intel Corporation (INTC) | 0.1 | $2.2M | 66k | 33.55 |
|
|
| Gossamer Bio (GOSS) | 0.1 | $2.1M | NEW | 800k | 2.63 |
|
| Biohaven (BHVN) | 0.1 | $2.1M | 140k | 15.01 |
|
|
| Optimizerx Corp Com New (OPRX) | 0.1 | $2.1M | 100k | 20.50 |
|
|
| Eliem Therapeutics (CLYM) | 0.1 | $2.0M | 1.0M | 2.01 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.1 | $2.0M | 900k | 2.22 |
|
|
| JPMorgan Chase & Co. (JPM) | 0.1 | $2.0M | 6.3k | 315.43 |
|
|
| Microsoft Corporation (MSFT) | 0.1 | $1.8M | 3.5k | 517.93 |
|
|
| Wal-Mart Stores (WMT) | 0.1 | $1.8M | 17k | 103.06 |
|
|
| Johnson & Johnson (JNJ) | 0.1 | $1.8M | 9.5k | 185.41 |
|
|
| Visa Com Cl A (V) | 0.1 | $1.7M | 4.9k | 341.40 |
|
|
| Walt Disney Company (DIS) | 0.1 | $1.7M | 15k | 114.50 |
|
|
| Kodiak Sciences (KOD) | 0.1 | $1.6M | 100k | 16.37 |
|
|
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 0.1 | $1.6M | 3.3k | 502.77 |
|
|
| Cognition Therapeutics (CGTX) | 0.1 | $1.6M | NEW | 1.2M | 1.35 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.1 | $1.6M | 128k | 12.65 |
|
|
| Verizon Communications (VZ) | 0.1 | $1.6M | 36k | 43.95 |
|
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $1.5M | 127k | 11.97 |
|
|
| Coca-Cola Company (KO) | 0.1 | $1.5M | 23k | 66.32 |
|
|
| Home Depot (HD) | 0.1 | $1.5M | 3.6k | 405.18 |
|
|
| Caredx (CDNA) | 0.1 | $1.5M | 100k | 14.54 |
|
|
| Exxon Mobil Corporation (XOM) | 0.1 | $1.4M | 13k | 112.75 |
|
|
| Procter & Gamble Company (PG) | 0.1 | $1.4M | 9.0k | 153.65 |
|
|
| Texas Instruments Incorporated (TXN) | 0.1 | $1.4M | 7.4k | 183.73 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.4M | 100k | 13.59 |
|
|
| Pfizer (PFE) | 0.1 | $1.4M | 53k | 25.48 |
|
|
| Viatris (VTRS) | 0.0 | $1.3M | 128k | 9.90 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $1.2M | -69% | 544k | 2.17 |
|
| Paypal Holdings (PYPL) | 0.0 | $1.2M | 17k | 67.06 |
|
|
| Tscan Therapeutics (TCRX) | 0.0 | $1.1M | 600k | 1.82 |
|
|
| Puma Biotechnology (PBYI) | 0.0 | $1.1M | 200k | 5.31 |
|
|
| American Assets Trust Inc reit (AAT) | 0.0 | $1.0M | 50k | 20.32 |
|
|
| Bioatla (BCAB) | 0.0 | $945k | 1.4M | 0.69 |
|
|
| UnitedHealth (UNH) | 0.0 | $940k | 2.7k | 345.28 |
|
|
| Ge Aerospace Com New (GE) | 0.0 | $901k | -39% | 3.0k | 300.87 |
|
| Kura Oncology (KURA) | 0.0 | $885k | 100k | 8.85 |
|
|
| Ge Vernova (GEV) | 0.0 | $847k | -43% | 1.4k | 614.95 |
|
| Fortrea Hldgs Common Stock (FTRE) | 0.0 | $842k | 100k | 8.42 |
|
|
| Netflix (NFLX) | 0.0 | $819k | -37% | 683.00 | 1199.60 |
|
| Ulta Salon, Cosmetics & Fragrance (ULTA) | 0.0 | $757k | -42% | 1.4k | 546.60 |
|
| Astria Therapeutics (ATXS) | 0.0 | $728k | 100k | 7.28 |
|
|
| Boeing Company (BA) | 0.0 | $696k | -96% | 3.2k | 215.84 |
|
| American Express Company (AXP) | 0.0 | $641k | -39% | 1.9k | 332.09 |
|
| Hldgs (UAL) | 0.0 | $608k | -37% | 6.3k | 96.51 |
|
| Passage Bio Com New (PASG) | 0.0 | $602k | NEW | 75k | 8.03 |
|
| Allstate Corporation (ALL) | 0.0 | $580k | -39% | 2.7k | 214.67 |
|
| Hewlett Packard Enterprise (HPE) | 0.0 | $579k | -41% | 24k | 24.56 |
|
| Amazon (AMZN) | 0.0 | $567k | -40% | 2.6k | 219.56 |
|
| Metropcs Communications (TMUS) | 0.0 | $547k | -39% | 2.3k | 239.34 |
|
| D Fluidigm Corp Del (LAB) | 0.0 | $530k | 408k | 1.30 |
|
|
| McDonald's Corporation (MCD) | 0.0 | $520k | -41% | 1.7k | 303.81 |
|
| Ford Motor Company (F) | 0.0 | $519k | -42% | 43k | 11.96 |
|
| Sealed Air (SEE) | 0.0 | $505k | -41% | 14k | 35.35 |
|
| Sherwin-Williams Company (SHW) | 0.0 | $484k | -40% | 1.4k | 346.36 |
|
| Atyr Pharma Com New (ATYR) | 0.0 | $484k | 671k | 0.72 |
|
|
| Omniab (OABI) | 0.0 | $480k | 300k | 1.60 |
|
|
| Chevron Corporation (CVX) | 0.0 | $469k | -42% | 3.0k | 155.29 |
|
| Paychex (PAYX) | 0.0 | $449k | -41% | 3.5k | 126.76 |
|
| Century Therapeutics (IPSC) | 0.0 | $448k | 900k | 0.50 |
|
|
| Adagio Therapeutics (IVVD) | 0.0 | $440k | 400k | 1.10 |
|
|
| Hormel Foods Corporation (HRL) | 0.0 | $400k | -42% | 16k | 24.74 |
|
| FedEx Corporation (FDX) | 0.0 | $399k | -41% | 1.7k | 235.88 |
|
| Clorox Company (CLX) | 0.0 | $376k | -40% | 3.1k | 123.28 |
|
| Macrogenics (MGNX) | 0.0 | $368k | 219k | 1.68 |
|
|
| Bolt Biotherapeutics (BOLT) | 0.0 | $356k | -59% | 67k | 5.32 |
|
| Gh Research Ordinary Shares (GHRS) | 0.0 | $344k | NEW | 24k | 14.30 |
|
| Whirlpool Corporation (WHR) | 0.0 | $341k | -42% | 4.3k | 78.60 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.0 | $320k | -31% | 116k | 2.75 |
|
| Athira Pharma | 0.0 | $248k | NEW | 60k | 4.14 |
|
| Metagenomi (MGX) | 0.0 | $66k | -85% | 28k | 2.37 |
|
| Pacific Biosciences of California (PACB) | 0.0 | $32k | NEW | 25k | 1.28 |
|
| Cassava Sciences (SAVA) | 0.0 | $21k | -97% | 7.1k | 2.91 |
|
Past Filings by Tang Capital Management
SEC 13F filings are viewable for Tang Capital Management going back to 2011
- Tang Capital Management 2025 Q3 filed Nov. 14, 2025
- Tang Capital Management 2025 Q2 filed Aug. 14, 2025
- Tang Capital Management 2025 Q1 filed May 15, 2025
- Tang Capital Management 2024 Q4 filed Feb. 14, 2025
- Tang Capital Management 2024 Q3 filed Nov. 14, 2024
- Tang Capital Management 2024 Q2 filed Aug. 14, 2024
- Tang Capital Management 2024 Q1 filed May 15, 2024
- Tang Capital Management 2023 Q4 filed Feb. 14, 2024
- Tang Capital Management 2023 Q3 filed Nov. 14, 2023
- Tang Capital Management 2023 Q2 filed Aug. 14, 2023
- Tang Capital Management 2023 Q1 filed May 15, 2023
- Tang Capital Management 2022 Q4 filed Feb. 14, 2023
- Tang Capital Management 2022 Q3 filed Nov. 14, 2022
- Tang Capital Management 2022 Q2 filed Aug. 15, 2022
- Tang Capital Management 2022 Q1 filed May 16, 2022
- Tang Capital Management 2021 Q4 filed Feb. 14, 2022